Search Site

Maryjane Anna Farr, MD

  • Associate Professor of Medicine at CUMC
  • Medical Director, Adult Heart Transplant Program
Maryjane Anna Farr, MD

Maryjane Farr, MD, MSc, FACC is an Associate Professor of Medicine at Columbia University Medical Center/New York-Presbyterian Hospital. Dr. Farr received her Doctorate in Medicine from Columbia University College of Physicians and Surgeons, AOA and Master's in Science at Columbia University Mailman School of Public Health.

Dr. Farr completed her internal medicine internship and residency at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Farr went on to complete an ACGME cardiovascular diseases fellowship at Weill Cornell Medical College. She completed advanced heart failure and transplantation fellowship training at Columbia University Medical Center, Montefiore Medical Center and The Brigham and Women's Hospital. Dr. Farr is board certified in Internal Medicine, Cardiovascular Diseases, Echocardiography and Heart Failure and Transplantation.

In 2009 Dr. Farr became a Patient-Oriented Research Scholar through an NIH training grant, completing a Master's in Science in 2011. In 2012 Dr. Farr was honored as a Heart Failure and Transplant Scholar, with the Shorin-Silverstein Grant from Columbia University Medical Center.

Dr. Farr has been a member of the UNOS Thoracic Committee since 2015, as Region 9 Representative and currently as the Heart Subcommittee Chair. She is on the Medical Advisory Board of LiveOn NY and a member fo the NY Cardiothoracic Transplant Consortium. Dr. Farr has been the Medical Director of Adult Heart Transplantation at NYP/Columbia since 2014.

Education & Training

  • Columbia University College of Physicians and Surgeons
  • MD, 1998 Columbia University College of Physicians and Surgeons
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Centers / Institutes / Programs

  • Center for Advanced Cardiac Care
  • Columbia Department of Surgery Heart Transplantation Program
  • Transplant Research Forum

Community Service

Fundraiser, LiveOn NY - 2016 NYC Marathon

Committees / Societies / Memberships

International Society of Heart and Lung Transplant

American College of Cardiology (Fellow)

American Heart Association

American Society of Transplantation

American College of Physicians

Research Interests

  • Cirrhotic cardiomyopathy
  • Primary graft failure after heart transplantation

NIH Grants

  • A RANDOMIZED, PARALLELGROUP,PLACEBOCONTROLLED,DOUBLEBLIND, EVENTDRIVEN,MULTICENTERPIVOTAL PHASE3 OUTCOME TRIAL OFEFFICACY&SAFETY OFORAL SGC STIMULATOR VERICIGUAT INSUBJ.WITH HFREF- VERICIGUAT GLOBAL STUDY (P&S Industry Clinical Trial)

    May 8 2017 - May 8 2022

    INTERPRET - INOTROPE, EVALUATION AND RESEARCH PATIENT REGISTRY (P&S Industry Clinical Trial)

    Jul 24 2015 - Jul 24 2020

    A DOUBLE-BLIND, RANDOMIZED, SHAM-PROCEDURE-CONTROLLED, PARALLEL-GROUP EFFICACY AND SAFETY STUDY OF ALLOGENEIC MESENCHYMAL PRECURSOR CELLS (CEP?41750) IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (P&S Industry Clinical Trial)

    Mar 13 2015 - Mar 13 2020

    TARGETING INFLAMMATION AND ALLOIMMUNITY IN HEART TRANSPLANT RECIPIENTS WITH TOCILIZUMAB , ( STUDY ) (Federal Gov)

    May 1 2018 - Apr 30 2019

    A PHASE I/II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF JVS-100 ADMINISTERED BY RETROGRADE DELIVERY TO COHORTS OF ADULTS WITH ISCHEMIC HEART FAILURE (P&S Industry Clinical Trial)

    Feb 28 2014 - Feb 28 2019

    A MULTICENTER, RANDOMIZED, DOUBLE-BLIND. PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF TRANSENDOCARDIAL INJECTION OF IXMYELOCEL-T IN SUBJECTS WITH HEART FAILURE DUE TO ISCHEMIC DILATED CARDIOMYOPATHY (P&S Industry Clinical Trial)

    Apr 23 2013 - Apr 23 2018

    A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF A SINGLE DOSE OF JVS-100 ADMIISTERED BY ENDOMYOCAARDIAL INJECTION TO COHORTS OF ADULTS WITH ESCHEMIC HEART FAILURE (P&S Industry Clinical Trial)

    Oct 3 2012 - Oct 3 2017

    AN OPEN LABEL DOSE ESCALATION STUDY TO EVALUATE THE SAFETY OF A SINGLE ESCALATING DOSE OF ACRX-100 ADMINISTERED BY (P&S Industry Clinical Trial)

    Apr 9 2010 - Apr 9 2015

    A REGISTRY TO ASSESS THE ONGOING SAFETY FOR SUBJECTS THAT HAVE BEEN RANDOMIZED AND COMPLETED A JUVENTAS SPONSORED HEART FAILURE PROTOCOL UNDER IND # 14203 (P&S Industry Clinical Trial)

    Sep 15 2014 - Jun 30 1999

Publications

1: See SB, Clerkin KJ, Kennel PJ, Zhang F, Weber MP, Rogers KJ, Chatterjee D,
Vasilescu ER, Vlad G, Naka Y, Restaino SW, Farr MA, Topkara VK, Colombo PC,
Mancini DM, Schulze PC, Levin B, Zorn E. Ventricular assist device elicits serum
natural IgG that correlates with the development of primary graft dysfunction
following heart transplantation. J Heart Lung Transplant. 2017 Mar 24. pii:
S1053-2498(17)31733-3. doi: 10.1016/j.healun.2017.03.018. [Epub ahead of print]
PubMed PMID: 28431981.


2: Davies RR, Farr M, Silvestry S, Callahan LR, Edwards L, Meyer DM, Uccellini K,
Chan KM, Rogers JG. The new United States heart allocation policy: Progress
through collaborative revision. J Heart Lung Transplant. 2017 Mar 21. pii:
S1053-2498(17)31707-2. doi: 10.1016/j.healun.2017.03.010. [Epub ahead of print]
PubMed PMID: 28396089.


3: Takeda K, Li B, Garan AR, Topkara VK, Han J, Colombo PC, Farr MA, Naka Y,
Takayama H. Improved outcomes from extracorporeal membrane oxygenation versus
ventricular assist device temporary support of primary graft dysfunction in heart
transplant. J Heart Lung Transplant. 2016 Dec 23. pii: S1053-2498(16)30466-1.
doi: 10.1016/j.healun.2016.12.006. [Epub ahead of print] PubMed PMID: 28087104.


4: Clerkin KJ, Farr MA, Restaino SW, Zorn E, Latif F, Vasilescu ER, Marboe CC,
Colombo PC, Mancini DM. Donor-specific anti-HLA antibodies with antibody-mediated
rejection and long-term outcomes following heart transplantation. J Heart Lung
Transplant. 2017 May;36(5):540-545. doi: 10.1016/j.healun.2016.10.016. Epub 2016
Nov 17. PubMed PMID: 27916323.


5: Clerkin KJ, Farr MA, Restaino SW, Ali ZA, Mancini DM. Dobutamine stress
echocardiography is inadequate to detect early cardiac allograft vasculopathy. J
Heart Lung Transplant. 2016 Aug;35(8):1040-1. doi: 10.1016/j.healun.2016.05.012.
Epub 2016 May 21. PubMed PMID: 27318788.


6: Varr BC, Restaino SW, Farr M, Scully B, Colombo PC, Naka Y, Mancini DM.
Infectious complications after cardiac transplantation in patients bridged with
mechanical circulatory support devices versus medical therapy. J Heart Lung
Transplant. 2016 Sep;35(9):1116-23. doi: 10.1016/j.healun.2016.04.016. Epub 2016
May 11. PubMed PMID: 27289301.


7: Lee M, Akashi H, Kato TS, Takayama H, Wu C, Xu K, Collado E, Weber MP, Kennel
PJ, Brunjes DL, Ji R, Naka Y, George I, Mancini D, Farr M, Schulze PC. Vascular
inflammation and abnormal aortic histomorphometry in patients after pulsatile-
and continuous-flow left ventricular assist device placement. J Heart Lung
Transplant. 2016 Sep;35(9):1085-91. doi: 10.1016/j.healun.2015.12.027. Epub 2016
Jan 6. PubMed PMID: 26899764; PubMed Central PMCID: PMC5376500.


8: Lewis M, Ginns J, Schulze C, Lippel M, Chai P, Bacha E, Mancini D, Rosenbaum
M, Farr M. Outcomes of Adult Patients With Congenital Heart Disease After Heart
Transplantation: Impact of Disease Type, Previous Thoracic Surgeries, and
Bystander Organ Dysfunction. J Card Fail. 2016 Jul;22(7):578-82. doi:
10.1016/j.cardfail.2015.09.002. Epub 2015 Nov 11. PubMed PMID: 26432646.


9: Kato TS, Armstrong HF, Schulze PC, Lippel M, Amano A, Farr M, Bacchetta M,
Bartels MN, Di Tullio MR, Homma S, Mancini D. Left and Right Ventricular
Functional Dynamics Determined by Echocardiograms Before and After Lung
Transplantation. Am J Cardiol. 2015 Aug 15;116(4):652-9. doi:
10.1016/j.amjcard.2015.05.027. Epub 2015 May 21. PubMed PMID: 26089014; PubMed
Central PMCID: PMC4522196.


10: Farr M, Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, Dove L, Jorde UP,
Takayama H, Emond J, Naka Y, Mancini D, Lefkowitch JH, Schulze PC. Combination of
liver biopsy with MELD-XI scores for post-transplant outcome prediction in
patients with advanced heart failure and suspected liver dysfunction. J Heart
Lung Transplant. 2015 Jul;34(7):873-82. doi: 10.1016/j.healun.2014.12.009. Epub
2014 Dec 23. PubMed PMID: 25851466; PubMed Central PMCID: PMC4941637.


11: Farr M, Schulze PC. Recent advances in the diagnosis and management of
cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo
imaging, cardiac biomarkers, and advanced heart failure therapies. Clin Med
Insights Cardiol. 2015 Jan 28;8(Suppl 1):67-74. doi: 10.4137/CMC.S15722.
eCollection 2014. Review. PubMed PMID: 25657603; PubMed Central PMCID:
PMC4310615.


12: Martin ST, Kato TS, Farr M, McKeen JT, Cheema F, Ji M, Ross A, Yerebakan H,
Naka Y, Takayama H, Restaino S, Mancini D, Schulze PC. Similar survival in
patients following heart transplantation receiving induction therapy using
daclizumab vs. basiliximab. Circ J. 2015;79(2):368-74. doi:
10.1253/circj.CJ-14-0718. Epub 2014 Dec 12. PubMed PMID: 25501951; PubMed Central
PMCID: PMC4967552.


13: Clerkin KJ, Thomas SS, Haythe J, Schulze PC, Farr M, Takayama H, Jorde UP,
Restaino SW, Naka Y, Mancini DM. Mechanical circulatory support as a bridge to
cardiac retransplantation: a single center experience. J Heart Lung Transplant.
2015 Feb;34(2):161-6. doi: 10.1016/j.healun.2014.09.033. Epub 2014 Sep 28. PubMed
PMID: 25455751; PubMed Central PMCID: PMC4936397.


14: Pronschinske KB, Qiu S, Wu C, Kato TS, Khawaja T, Takayama H, Naka Y,
Templeton DL, George I, Farr MA, Mancini DM, Schulze PC. Neutrophil
gelatinase-associated lipocalin and cystatin C for the prediction of clinical
events in patients with advanced heart failure and after ventricular assist
device placement. J Heart Lung Transplant. 2014 Dec;33(12):1215-22. doi:
10.1016/j.healun.2014.06.007. Epub 2014 Jun 23. PubMed PMID: 25049066; PubMed
Central PMCID: PMC4252882.


15: Kato TS, Jiang J, Schulze PC, Jorde U, Uriel N, Kitada S, Takayama H, Naka Y,
Mancini D, Gillam L, Homma S, Farr M. Serial echocardiography using tissue
Doppler and speckle tracking imaging to monitor right ventricular failure before
and after left ventricular assist device surgery. JACC Heart Fail. 2013
Jun;1(3):216-22. doi: 10.1016/j.jchf.2013.02.005. Epub 2013 Jun 3. PubMed PMID:
24621873; PubMed Central PMCID: PMC3997790.


16: Sera F, Kato TS, Farr M, Russo C, Jin Z, Marboe CC, Di Tullio MR, Mancini D,
Homma S. Left ventricular longitudinal strain by speckle-tracking
echocardiography is associated with treatment-requiring cardiac allograft
rejection. J Card Fail. 2014 May;20(5):359-64. doi:
10.1016/j.cardfail.2014.02.006. Epub 2014 Feb 21. PubMed PMID: 24561182.


17: Kato TS, Kitada S, Yang J, Wu C, Takayama H, Naka Y, Farr M, Mancini DM,
Schulze PC. Relation of preoperative serum albumin levels to survival in patients
undergoing left ventricular assist device implantation. Am J Cardiol. 2013 Nov
1;112(9):1484-8. doi: 10.1016/j.amjcard.2013.06.023. Epub 2013 Jul 25. PubMed
PMID: 23891248; PubMed Central PMCID: PMC4074378.


18: Kitada S, Kato TS, Thomas SS, Conwell SD, Russo C, Di Tullio MR, Farr M,
Schulze PC, Uriel N, Jorde UP, Takayama H, Naka Y, Homma S, Mancini DM.
Pre-operative echocardiographic features associated with persistent mitral
regurgitation after left ventricular assist device implantation. J Heart Lung
Transplant. 2013 Sep;32(9):897-904. doi: 10.1016/j.healun.2013.06.004. Epub 2013
Jul 11. PubMed PMID: 23850122; PubMed Central PMCID: PMC4278424.


19: Kato TS, Collado E, Khawaja T, Kawano Y, Kim M, Farr M, Mancini DM, Schulze
PC. Response to letter regarding article, "Value of peak exercise oxygen
consumption combined with B-type natriuretic peptide levels for optimal timing of
cardiac transplantation". Circ Heart Fail. 2013 May;6(3):e42. PubMed PMID:
23844429; PubMed Central PMCID: PMC4959007.


20: Kato TS, Cheema FH, Yang J, Kawano Y, Takayama H, Naka Y, Farr M, Lederer DJ,
Baldwin MR, Jin Z, Homma S, Mancini DM, Schulze PC. Preoperative serum albumin
levels predict 1-year postoperative survival of patients undergoing heart
transplantation. Circ Heart Fail. 2013 Jul;6(4):785-91. doi:
10.1161/CIRCHEARTFAILURE.111.000358. Epub 2013 May 14. PubMed PMID: 23674361;
PubMed Central PMCID: PMC4074373.


21: Kim MS, Kato TS, Farr M, Wu C, Givens RC, Collado E, Mancini DM, Schulze PC.
Hepatic dysfunction in ambulatory patients with heart failure: application of the
MELD scoring system for outcome prediction. J Am Coll Cardiol. 2013 Jun
4;61(22):2253-61. doi: 10.1016/j.jacc.2012.12.056. Epub 2013 Apr 3. PubMed PMID:
23563127; PubMed Central PMCID: PMC3939720.


22: Schulze PC, Jiang J, Yang J, Cheema FH, Schaeffle K, Kato TS, Farr M,
Restaino S, Deng M, Maurer M, Horn E, Latif F, Colombo PC, Jorde U, Uriel N,
Haythe J, Bijou R, Drusin R, Lee SH, Takayama H, Naka Y, Mancini DM. Preoperative
assessment of high-risk candidates to predict survival after heart
transplantation. Circ Heart Fail. 2013 May;6(3):527-34. doi:
10.1161/CIRCHEARTFAILURE.112.000092. Epub 2013 Mar 15. PubMed PMID: 23505300;
PubMed Central PMCID: PMC4283202.


23: Penn MS, Mendelsohn FO, Schaer GL, Sherman W, Farr M, Pastore J, Rouy D,
Clemens R, Aras R, Losordo DW. An open-label dose escalation study to evaluate
the safety of administration of nonviral stromal cell-derived factor-1 plasmid to
treat symptomatic ischemic heart failure. Circ Res. 2013 Mar 1;112(5):816-25.
doi: 10.1161/CIRCRESAHA.111.300440. Epub 2013 Feb 21. PubMed PMID: 23429605.


24: Kato TS, Stevens GR, Jiang J, Schulze PC, Gukasyan N, Lippel M, Levin A,
Homma S, Mancini D, Farr M. Risk stratification of ambulatory patients with
advanced heart failure undergoing evaluation for heart transplantation. J Heart
Lung Transplant. 2013 Mar;32(3):333-40. doi: 10.1016/j.healun.2012.11.026. PubMed
PMID: 23415315; PubMed Central PMCID: PMC4119928.


25: Kato TS, Collado E, Khawaja T, Kawano Y, Kim M, Farr M, Mancini DM, Schulze
PC. Value of peak exercise oxygen consumption combined with B-type natriuretic
peptide levels for optimal timing of cardiac transplantation. Circ Heart Fail.
2013 Jan;6(1):6-14. doi: 10.1161/CIRCHEARTFAILURE.112.968123. Epub 2012 Nov 30.
PubMed PMID: 23204059.


26: Akashi H, Kato TS, Takayama H, Naka Y, Farr M, Mancini D, Schulze PC. Outcome
of patients with cardiac sarcoidosis undergoing cardiac
transplantation--single-center retrospective analysis. J Cardiol. 2012
Nov;60(5):407-10. doi: 10.1016/j.jjcc.2012.07.013. Epub 2012 Aug 11. PubMed PMID:
22890069.


27: Chavarria N, Kato TS, Khan R, Chokshi A, Collado E, Akashi H, Takayama H,
Naka Y, Farr M, Mancini D, Schulze PC. Increased levels of retinol binding
protein 4 in patients with advanced heart failure correct after hemodynamic
improvement through ventricular assist device placement. Circ J.
2012;76(9):2148-52. Epub 2012 Jun 12. PubMed PMID: 22785609.


28: Kato TS, Takayama H, Yoshizawa S, Marboe C, Schulze PC, Farr M, Naka Y,
Mancini D, Maurer MS. Cardiac transplantation in patients with hypertrophic
cardiomyopathy. Am J Cardiol. 2012 Aug 15;110(4):568-74. doi:
10.1016/j.amjcard.2012.04.030. Epub 2012 May 15. PubMed PMID: 22591671.


29: Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP, Mancini DM, Naka
Y, Schulze PC. Liver dysfunction as a predictor of outcomes in patients with
advanced heart failure requiring ventricular assist device support: Use of the
Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring
system. J Heart Lung Transplant. 2012 Jun;31(6):601-10. doi:
10.1016/j.healun.2012.02.027. Epub 2012 Mar 28. PubMed PMID: 22458997; PubMed
Central PMCID: PMC3358456.


30: Chokshi A, Cheema FH, Schaefle KJ, Jiang J, Collado E, Shahzad K, Khawaja T,
Farr M, Takayama H, Naka Y, Mancini DM, Schulze PC. Hepatic dysfunction and
survival after orthotopic heart transplantation: application of the MELD scoring
system for outcome prediction. J Heart Lung Transplant. 2012 Jun;31(6):591-600.
doi: 10.1016/j.healun.2012.02.008. Epub 2012 Mar 27. PubMed PMID: 22458996;
PubMed Central PMCID: PMC3358427.


31: Kato TS, Ota T, Schulze PC, Farr M, Jorde U, Takayama H, Naka Y, Yamashita T,
Mancini DM. Asymmetric pattern of cerebrovascular lesions in patients after left
ventricular assist device implantation. Stroke. 2012 Mar;43(3):872-4. doi:
10.1161/STROKEAHA.111.639682. Epub 2011 Dec 29. PubMed PMID: 22207509.


32: Kato TS, Farr M, Schulze PC, Maurer M, Shahzad K, Iwata S, Homma S, Jorde U,
Takayama H, Naka Y, Gillam L, Mancini D. Usefulness of two-dimensional
echocardiographic parameters of the left side of the heart to predict right
ventricular failure after left ventricular assist device implantation. Am J
Cardiol. 2012 Jan 15;109(2):246-51. doi: 10.1016/j.amjcard.2011.08.040. Epub 2011
Nov 14. PubMed PMID: 22088200.


33: Kato TS, Chokshi A, Singh P, Khawaja T, Iwata S, Homma S, Akashi H, Cheema F,
Yang J, Takayama H, Naka Y, Farr M, Mancini D, Schulze PC. Markers of
extracellular matrix turnover and the development of right ventricular failure
after ventricular assist device implantation in patients with advanced heart
failure. J Heart Lung Transplant. 2012 Jan;31(1):37-45. doi:
10.1016/j.healun.2011.10.007. Epub 2011 Nov 9. PubMed PMID: 22071239.


34: Kato TS, Schulze PC, Yang J, Chan E, Shahzad K, Takayama H, Uriel N, Jorde U,
Farr M, Naka Y, Mancini D. Pre-operative and post-operative risk factors
associated with neurologic complications in patients with advanced heart failure
supported by a left ventricular assist device. J Heart Lung Transplant. 2012
Jan;31(1):1-8. doi: 10.1016/j.healun.2011.08.014. Epub 2011 Oct 8. PubMed PMID:
21986099; PubMed Central PMCID: PMC4945759.


35: Kato TS, Chokshi A, Singh P, Khawaja T, Cheema F, Akashi H, Shahzad K, Iwata
S, Homma S, Takayama H, Naka Y, Jorde U, Farr M, Mancini DM, Schulze PC. Effects
of continuous-flow versus pulsatile-flow left ventricular assist devices on
myocardial unloading and remodeling. Circ Heart Fail. 2011 Sep;4(5):546-53. doi:
10.1161/CIRCHEARTFAILURE.111.962142. Epub 2011 Jul 15. PubMed PMID: 21765125;
PubMed Central PMCID: PMC3178740.


36: Sims DB, Uriel N, González-Costello J, Deng MC, Restaino SW, Farr MA,
Takayama H, Mancini DM, Naka Y, Jorde UP. Human immunodeficiency virus infection
and left ventricular assist devices: a case series. J Heart Lung Transplant. 2011
Sep;30(9):1060-4. doi: 10.1016/j.healun.2011.03.004. Epub 2011 Apr 22. PubMed
PMID: 21515076.


37: Uriel N, Naka Y, Colombo PC, Farr M, Pak SW, Cotarlan V, Albu JB, Gallagher
D, Mancini D, Ginsberg HN, Jorde UP. Improved diabetic control in advanced heart
failure patients treated with left ventricular assist devices. Eur J Heart Fail.
2011 Feb;13(2):195-9. doi: 10.1093/eurjhf/hfq204. Epub 2010 Nov 23. PubMed PMID:
21098576; PubMed Central PMCID: PMC3025668.


38: Garan AR, Uriel N, Sayer G, Sims D, Zahner D, Farr M, Mancini D, Jorde UP.
Alteration in systemic vascular resistance and cardiac output during acute
cellular rejection and recovery in heart transplant recipients. J Heart Lung
Transplant. 2010 Mar;29(3):382-4. doi: 10.1016/j.healun.2009.08.015. Epub 2009
Oct 28. PubMed PMID: 19875310.


39: Uriel N, Vainrib A, Jorde UP, Cotarlan V, Farr M, Cheema FH, Naka Y, Mancini
D, Colombo PC. Mediastinal radiation and adverse outcomes after heart
transplantation. J Heart Lung Transplant. 2010 Mar;29(3):378-81. doi:
10.1016/j.healun.2009.08.011. Epub 2009 Oct 4. PubMed PMID: 19804988.


40: Uriel N, Jorde UP, Cotarlan V, Colombo PC, Farr M, Restaino SW, Lietz K, Naka
Y, Deng MC, Mancini D. Heart transplantation in human immunodeficiency
virus-positive patients. J Heart Lung Transplant. 2009 Jul;28(7):667-9. doi:
10.1016/j.healun.2009.04.005. Epub 2009 May 6. PubMed PMID: 19560693.


41: Farr M, Rubin AI, Mangurian C, Scully B, Silvers DN, Husain S, Grossman ME,
Mancini D. Late syphilis in a cardiac transplant patient. J Heart Lung
Transplant. 2006 Mar;25(3):358-61. Epub 2005 Dec 20. PubMed PMID: 16507433.


42: Farr MA, Basson CT. Sparking the failing heart. N Engl J Med. 2004 Jul
8;351(2):185-7. PubMed PMID: 15247360.